|
The Key Features |
-
Triphasic patterns
(blastemal, stromal, and epithelial cell types),
favorable histology;
-
WAGR syndrome
(del(11p13), WT1), Beckwith-Wiedemann syndrome (WT2, 11p15),
Hemihypertrophy, Denys-Drash syndrome (WT1, 11p13);
Familial nephroblastoma (FWT1, 17q12-21; FWT2,
19q13.3-13.4);
-
Unfavorable histology,
diffuse nuclear atypia.
|
|
|
CLINICAL FEATURES |
-
Malignant embryonal neoplasm
derived from nephrogenic blastemal cells;
-
Most common genitourinary cancer in
children, ~1/8,000 children, ~400 new cases each year in the US;
-
Slight higher incidence in girls,
male to female ratio of 0.6-0.9 to 1.0;
-
Mean age at diagnosis, 36 and 42
months for males and females, respectively. 98% of cases occur
in individuals under 10 years of age. Rarely occur in adults;
-
~10% of nephroblastomas are
associated with some well-characterized dysmorphic syndromes:
WAGR syndrome (Wilms' tumor, aniridia, genitourinary
malformation, mental retardation), 30% risk of developing a
nephroblastoma, consistent somatic del(11p13) that encodes
WT1; Beckwith-Wiedemann syndrome (WT2, 11p15);
Hemihypertrophy; Denys-Drash syndrome (WT1, 11p13);
Familial nephroblastoma (FWT1, 17q12-21; FWT2,
19q13.3-13.4);
-
Synchronous multicentric masses in
a single kidney and bilateral primary lesions are observed in 7%
and 5% of cases;
-
Most common clinical presentation:
presence of an abdominal mass. Abdominal pain, hematuria,
hypertension, and symptoms related to traumatic rupture are also
common;
-
Imaging usually reveals one or more
intrarenal sharply demarcated and heterogeneous masses.
|
|
GROSS FINDINGS |
-
Usually solitary, round, capsulated
and sharply demarcated with a lobulated appearance due to
prominent septa;
-
Cut surface: uniform, pale, gray or
tan and soft. The mature stromal elements are usually firm and
whorled;
-
Often cystic changes, hemorrhage
and necrosis;
-
Commonly local extension into the
renal vein and metastases to regional lymph nodes.
|
|
MICROSCOPIC FINDINGS |
-
Triphasic patterns, blastemal,
stromal, and epithelial cell types at various proportions;
-
Blastemal Component: present
in most cases and may be the only element. Arranged in
serpentine, nodular, basaloid or diffuse pattern. Blastemal
cells: small, closely packed with minimal differentiation and
scant cytoplasm; usually rounded or polygonal but may be
slightly elongated; small and regular nuclei with evenly
distributed, slightly coarse chromatin and small nucleoli;
indistinct cell borders and prominent overlapping of nuclei.
Mitotic figures are numerous in most specimens;
-
Epithelial Component:
present in most nephroblastomas. Several different patterns:
-
Primitive rosette-like
structures, tubular or papillary elements that recapitulate
various stages of normal nephrogenesis;
-
Glomerular structures
may closely resemble those of normal kidneys;
-
Foci of more mature cells with low
mitotic rates and increasing cytoplasm, particularly following therapy;
-
Heterologous epithelial
differentiation: most commonly mucinous and squamous
epithelia, and occasionally ciliated epithelium;
-
Stromal Component: myxoid
and spindle cells resembling embryonic mesenchyme in nearly all
specimens, and form the matrix for most of the blastemal and
epithelial foci. Smooth muscle and fibroblasts may be present
with variable degrees of differentiation. Skeletal muscle is the
most common heterologous stromal cell type. More primitive
myoblastic elements can also be found, including the condensed
mesenchyme characteristic of the cambium layer of botryoid
embryonal rhabdomyosarcoma;
-
Other stromal differentiation:
adipose tissue, cartilage, osteoid, mature ganglion cells,
and neuroglial tissue. This heterogeneity may be so prominent as
to suggest a teratoma.
-
Nuclear anaplasia:
-
Extreme
nuclear atypia and hyperchromasia rather than to a lack of
cellular differentiation;
-
Histologic Criteria for Anaplasia:
multipolar polyploid mitotic figure, and nuclear enlargement with
hyperchromasia;
-
Focal anaplasia: presence of
one or a few sharply localized regions of anaplasia within a
primary tumor, and the remaining majority of the tumor contain no significant
nuclear atypia.
|
|
DIFFERENTIAL DIAGNOSES |
|
|
|
IMMUNOHISTOCHEMISTRY AND SPECIAL STAINS |
-
WT1 protein, confined to the
nucleus, variable and correlate with tumor histology;
-
Bastemal cells regularly express
vimentin and maybe neuron-specific enolase, but other
differentiation markers are usually absent.
|
|
CYTOGENETIC STUDIES |
|
Syndromes
Associated with Highest Risk of Nephroblastoma
|
Other Conditions Associated with
Nephroblastoma
|
-
Wilms-aniridia-genital anomaly-retardation (WAGR)
syndrome (WT1, 11p13)
-
Beckwith-Wiedemann
syndrome (WT2, 11p15)
-
Hemihypertrophy
-
Denys-Drash syndrome
(WT1, 11p13)
-
Familial
nephroblastoma (FWT1, 17q12-21; FWT2,
19q13.3-13.4)
|
-
Frasier's syndrome (WT1,
11p13)
-
Simpson-Golabi-Behmel
syndrome (GPC3, Xq26)
-
Renal or genital
malformations
-
Cutaneous nevi,
angiomas
-
Trisomy 18
-
Klippel-Trenaunay
syndrome
-
Neurofibromatosis
-
Bloom's syndrome
-
Perlman's syndrome
-
Sotos' syndrome
-
Cerebral gigantism
|
|
|
TREATMENT AND PROGNOSIS |
-
Most tumors in the favorable group are
highly responsive to chemotherapy. The prognosis is not affected by
tumor size or weight. The overall 4-year survival rate for patients
with favorable histology nephroblastomas of all stages approaches
90%. The most significant unfavorable prognostic factors are age at
detection, high stage, and unfavorable histology (presence of
nuclear anaplasia).
-
Dactinomycin and vincristine are the
most effective drugs for most patients with favorable histology
tumors and are now in standard use around the world. These drugs are
used in conjunction with surgery, without radiotherapy, for all
patients with stage I and II lesions with favorable histology.
Radiotherapy and more toxic chemotherapeutic agents are reserved for
patients with stage III and IV disease
|
|
REFERENCES |
- AFIP, tumor of the kidney,
bladder and related urinary structures, series 4;
|